White label ELPA - ClinicalTrials.eu

Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

Recruiting

3 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
Study on Colchicine for Preventing Artery Narrowing in Patients with Lower Extremity Artery Disease

Recruiting

3 1 1 1
Investigated drugs:
- Colchicine
Study on the Safety and Effects of Karonudib for Patients with Advanced Leukemia, Lymphoma, and Multiple Myeloma

Recruiting

1 1 1 1
Investigated diseases:
- Haematological malignancy
Investigated drugs:
- Idarubicin Hydrochloride
Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

Recruiting

3 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Dostarlimab
+7
Study on Botulinum Toxin A Injection for Patients with Large Incisional Hernia

Recruiting

3 1 1
Investigated diseases:
- Incisional hernia
Investigated drugs:
- Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

Recruiting

2 1 1 1
Investigated diseases:
- HIV infection
- Obesity
Investigated drugs:
- Semaglutide
Study on FOLFIRINOX, Pembrolizumab, and SABR for Patients with Borderline Resectable Pancreatic Cancer

Recruiting

1 1 1 1
Investigated diseases:
- Pancreatic carcinoma
- Pancreatic carcinoma metastatic
Investigated drugs:
Study on Propofol and Remifentanil for Patients with Heart Disease Undergoing Cardiac Anesthesia with Cardiopulmonary Bypass

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Remifentanil
- Propofol
Study on the Safety and Effectiveness of LIS1 for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

Recruiting

1 1 1
Investigated diseases:
- T-cell lymphoma
Investigated drugs:
- Anti-T Lymphocyte Immunoglobulin For Human Use, Pig
Study on Bicalutamide and Drug Combination for Patients with Unfavorable Intermediate/High-Risk Prostate Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- Bicalutamide

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies